• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsAlebund Pharmaceuticals (Jiangsu)
    Picture of Alebund Pharmaceuticals (Jiangsu) logo

    9637 — Alebund Pharmaceuticals (Jiangsu) Share News

    HK$17.480.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapSucker Stock
    • Market Cap
      HK$6.09bn
    • Enterprise Value
      HK$5.13bn
    • Revenue
      CNY30.56m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • 9637 Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    9637 Dividends
    • Brief: Alebund Pharmaceuticals (Jiangsu) Board Resolves To Repurchase H Shares Up To Hk$100 Million

      Tue 18:43
    • Brief: Alebund Pharmaceuticals (Jiangsu) Says IND Application For AP308 Cleared By U.S. FDA

      08/09/2026 16:21
    • Crealights, Baige, Alebund Pharmaceuticals jump in Hong Kong debut

      29/06/2026 06:03
    • Brief: Alebund Pharmaceuticals (Jiangsu) Sets Final Offer Price At HK$22.6 Per Offer Share

      26/06/2026 16:37

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.